Endoscope Reprocessing Market is expanding as healthcare providers place greater emphasis on infection prevention, minimally invasive procedures, and reliable cleaning and disinfection workflows. Reusable endoscopes can present contamination risks when reprocessing is inadequate, increasing the need for effective disinfectants, automated systems, drying solutions, storage systems, and traceability technologies.

Download a free sample copy of the Endoscope Reprocessing market report to understand detailed coverage and inclusions in the final report

Market Size & Key Metrics

Market size, 2025: USD 1.8 billion
Estimated market size, 2026: USD 2.4 billion
Projected market size, 2033: USD 3.0 billion
CAGR, 2026–2033: 6.8%
Largest product segment in 2025: High-level disinfectants and test strips, with a 29.7% revenue share
Largest end-use segment in 2025: Ambulatory surgical centers, with a 57.0% revenue share
Largest regional market in 2025: North America, with a 37.8% revenue share

Core Market Drivers & Trends

1. Rising Diagnostic Volumes and Infection Risks

The increasing use of endoscopic procedures for diagnosis and treatment is creating stronger demand for dependable reprocessing solutions. The growing burden of respiratory and gastrointestinal diseases is contributing to higher procedure volumes, while concerns about healthcare-associated infections are encouraging healthcare facilities to strengthen cleaning and disinfection protocols.

Reusable endoscopes can become vectors for microbial transmission when contamination persists despite cleaning procedures. This makes effective reprocessing important for hospitals, clinics, diagnostic centers, and ambulatory surgical facilities. Regulatory attention and stricter infection-control requirements are also encouraging healthcare providers to adopt advanced reprocessing systems.

2. The Shift From High-Level Disinfection (HLD) to Sterilization

Healthcare facilities are increasingly evaluating advanced approaches to improve the safety and effectiveness of endoscope reprocessing. High-level disinfectants and test strips remained the leading product category in 2025, accounting for 29.7% of revenue. Their role in infection prevention makes them an essential component of reprocessing workflows.

At the same time, automated reprocessing technologies are receiving greater attention because they can standardize workflows, improve efficiency, and reduce opportunities for human error. Advanced systems can incorporate sensors and automation to streamline different stages of reprocessing.

3. AI and Cloud-Based Digital Traceability

Digital technologies are becoming increasingly important in endoscope reprocessing. Automated systems equipped with advanced sensors, robotics, and artificial intelligence can help streamline workflows and reduce the risk of human error. Digitalization can also improve traceability and compliance across disinfection processes.

The growing integration of digital technologies into endoscopy is particularly relevant to ambulatory surgical centers, where procedure volumes are increasing. These developments are creating opportunities for manufacturers to differentiate products through automation, connectivity, monitoring, and workflow management capabilities.

4. The Ambulatory Surgical Center (ASC) Surge

Ambulatory surgical centers represented the largest end-use segment, accounting for 57.0% of revenue in 2025. The increase in outpatient endoscopic procedures is contributing to demand for efficient reprocessing solutions. ASCs need dependable workflows that can support procedure volumes while maintaining infection-control standards.

Hospitals also represent an important market because they conduct a broad range of diagnostic and therapeutic endoscopic procedures. Rising chronic disease prevalence and patient demand for hospital-based care are expected to support continued adoption of reprocessing products and systems.

Market Restraints & Headwinds

Despite strong demand, the market faces several challenges. Reprocessing reusable endoscopes involves multiple stages, including cleaning, disinfection, drying, storage, quality assurance, and tracking. The complexity of these workflows can increase operational requirements and create opportunities for human error if protocols are not consistently followed.

Single-use disposable endoscopes also represent a notable substitute because they eliminate the need for conventional reprocessing after each procedure. As healthcare providers evaluate infection-control strategies, disposable technologies could influence demand for reusable-device reprocessing solutions.

Regulatory requirements represent another important consideration. Endoscopes have intricate designs and come into direct contact with bodily fluids, making effective cleaning and disinfection challenging. Consequently, healthcare facilities must maintain stringent procedures and comply with evolving safety requirements.

Regional Highlights

North America dominated the market with a 37.8% revenue share in 2025, supported by established healthcare infrastructure, high healthcare expenditure, and the prevalence of conditions requiring endoscopic procedures. Asia Pacific is projected to be the fastest-growing regional market during the forecast period.

The U.S. held the largest country-level market share in 2025, while Canada is anticipated to record the fastest growth during the forecast period. Europe is also expected to register significant growth, supported by product launches, regulatory developments, and technological advancements in endoscopy and reprocessing.

AI in Endoscopy Market : AI-powered endoscopy software is improving real-time lesion detection and diagnostic assistance, with recent collaborations focused on expanding the use of AI across gastroscopy and colonoscopy procedures.

FAQs

What is driving endoscope reprocessing market growth?

Increasing endoscopic procedure volumes, concerns about contamination and healthcare-associated infections, preference for minimally invasive procedures, stricter infection-control requirements, and the adoption of automated technologies are supporting market growth.

Which segment leads the endoscope reprocessing market?

High-level disinfectants and test strips led the product segment with a 29.7% revenue share in 2025, while ambulatory surgical centers led the end-use segment with a 57.0% revenue share.

Key Endoscope Reprocessing Companies:

Cantel Medical
Fortive Corporation
Olympus Corporation
Ecolab
Getinge AB
STERIS
Steelco S.p.A
ARC Group of Companies Inc.
Metrex Research, LLC.
Shinva Medical Instrument Co. Ltd.
Belimed

About us:

Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.

Why Digital Workflows Matter for the Future of Endoscope Reprocessing

The global endoscope reprocessing market size was valued at USD 1.8 billion in 2025 and is projected to grow from USD 2.4 billion in 2026 to USD 3.0 billion